SK Biopharmaceuticals Co Ltd
KRX:326030

Watchlist Manager
SK Biopharmaceuticals Co Ltd Logo
SK Biopharmaceuticals Co Ltd
KRX:326030
Watchlist
Price: 104 000 KRW -0.1% Market Closed
Market Cap: 8.1T KRW
Have any thoughts about
SK Biopharmaceuticals Co Ltd?
Write Note

SK Biopharmaceuticals Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SK Biopharmaceuticals Co Ltd
Gross Profit Peer Comparison

Comparables:
000100
008930
128940
S
000250
C
068760

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
SK Biopharmaceuticals Co Ltd
KRX:326030
Gross Profit
â‚©320.8B
CAGR 3-Years
137%
CAGR 5-Years
211%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Gross Profit
â‚©579.4B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
7%
Hanmi Science Co Ltd
KRX:008930
Gross Profit
â‚©241.2B
CAGR 3-Years
23%
CAGR 5-Years
19%
CAGR 10-Years
13%
Hanmi Pharm Co Ltd
KRX:128940
Gross Profit
â‚©875.2B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Gross Profit
â‚©99.3B
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
5%
C
Celltrion Pharm Inc
KOSDAQ:068760
Gross Profit
â‚©109.6B
CAGR 3-Years
4%
CAGR 5-Years
17%
CAGR 10-Years
11%

See Also

What is SK Biopharmaceuticals Co Ltd's Gross Profit?
Gross Profit
320.8B KRW

Based on the financial report for Dec 31, 2023, SK Biopharmaceuticals Co Ltd's Gross Profit amounts to 320.8B KRW.

What is SK Biopharmaceuticals Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
211%

Over the last year, the Gross Profit growth was 54%. The average annual Gross Profit growth rates for SK Biopharmaceuticals Co Ltd have been 137% over the past three years , 211% over the past five years .

Back to Top